FibroGen Inc
(LTS:0IL8)
$
0.3747
-0.0004 (-0.11%)
Market Cap: 37.45 Mil
Enterprise Value: 43.12 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 37/100 FibroGen Inc at Leerink Global Healthcare Conference Transcript
Feb 25, 2020 / 08:30PM GMT
Release Date Price:
$43.38
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst
Relatively recently appointed CEO, Enrique Conterno, and other members of the FibroGen team. Hi, Peony. So welcome to GHC this year.
Enrique A. Conterno
FibroGen, Inc. - CEO & Director
Thank you, Geoff.
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst
Your first GHC, how is it going?
Enrique A. Conterno
FibroGen, Inc. - CEO & Director
I think it's going awesome. We had a packed agenda today, met with a number of investors. Very good.
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst
Good.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot